Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CYTOFAltamira Therapeutics Ltd.
| Figure | CYTOFAltamira Therapeutics Ltd.FY2023 · Dec |
|---|---|
| Revenue | $379.00 |
| Revenue, yoy | −99.9% |
| Net income | $8.46M |
| Net income, yoy | −96.4% |
| Net margin | — |
| Free cash flow | $6.22M |
| FCF margin | — |
| EPS, diluted | $2.99 |
Add another company.
Annual · FY2021–FY2023 · USD
From SEC EDGARSame fiscal periods, as filed